Differential Target Multiplexed Spinal Cord Stimulator: A Review of Preclinical/Clinical Data and Hardware Advancement

References

• Shealy CN , MortimerJT , ReswickJB. Electrical inhibition of pain by stimulation of the dorsal columns: preliminary clinical report. Anesth. Analg.46(4), 489–491 (1967).
   PubMed Web of Science ®Google Scholar
• North RB , KiddDH , FarrokhiF , PiantadosiSA. Spinal cord stimulation versus repeated lumbosacral spine surgery for chronic pain: a randomized, controlled trial. Neurosurgery56(98-106), 106–107 (2005).
   Google Scholar
• Kumar K , TaylorRS , JacquesLet al. Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomized controlled trial in patients with failed back surgery syndrome. Pain132, 179–188 (2007).
   PubMed Web of Science ®Google Scholar
• Melzack R , WallPD. Pain mechanisms: a new theory. Science150, 971–979 (1965).
   PubMed Web of Science ®Google Scholar
• Van Buyten J-P , WillieF , SmetIet al. Therapy-related explants after spinal cord stimulation: results of an international retrospective chart review study. Neuromodulation20(7), 642–649 (2017).
   PubMed Web of Science ®Google Scholar
• Deer T , SlavinKV , AmirdelfanKet al. Success using neuromodulation with BURST (SUNBURST) study: results from a prospective, randomized controlled trial using a novel burst waveform. Neuromodulation21, 56 (2018).
   PubMed Web of Science ®Google Scholar
• Kapural L , YuC , DoustNWet al. Noval 10-kHz high frequency therapy (HF10 therapy) is superior to traditional low-frequency spinal cord stimulation for the treatment of chronic back and leg pain: the SENZA-RCT randomized controlled trial. Anesthesiology123, 851–860 (2015).
   PubMed Web of Science ®Google Scholar
• Hatheway JA , MangalV , FishmanMet al. Long-term efficacy of a novel spinal cord stimulation clinical workflow using kilohertz stimulation: twelve-month results from the Vectors study. Neuromodulation24(3), 556–565 (2020).
   PubMed Web of Science ®Google Scholar
• Vallejo R , TilleyDM , VogelL , BenyaminR. The role of glia and the immune system in the development and maintenance of neuropathic pain. Pain Pract.10, 167–184 (2010).
   PubMed Web of Science ®Google Scholar
• Ruiz-Sauri A , Orduña-VallsJM , Blasco-SerraAet al. Glia to neuron ratio in the posterior aspect of the human spinal cord at thoracic segments relevant to spinal cord stimulation. J. Anat.235, 997–1006 (2019).
   PubMed Web of Science ®Google Scholar
• Vallejo R , KelleyCA , GuptaA , SmithWJ , VallejoA , CedeñoDL. Modulation of neuroglial interactions using differential target multiplexed spinal cord stimulation in an animal model of neuropathic pain. Mol. Pain16, 1744806920918057 (2020).
   Web of Science ®Google Scholar
• Vallejo R , CedenoDL , PlattDCet al. Differential target multiplexed SCS using reduced energy parameters in an animal model of neuropathic pain. NANS Mid-Year 2021 Poster Presentation. Orlando, Finland (15–17 July 2021).
   Google Scholar
• Fishman M , CordnerH , JustizRet al. Twelve-month results from a multicenter, open-label, randomized controlled clinical trial comparing differential target multiplexed spinal cord stimulation and traditional spinal cord stimulation in subjects with chronic intractable back pain and leg pain. Pain Pract.21(8), 912–923 (2021).
   PubMed Web of Science ®Google Scholar
• Vallejo R , FishmanM , CordnerHet al. Characterization of surgery-naive patients within the differential target multiplexed SCS (DTM SCS) randomized controlled study. NANS Mid-Year 2021 Poster Presentation. Orlando, Finland (15–17 July 2021).
   Google Scholar
• Vallejo R . Prospective, single arm, multi-center, post-market study to optimize DTM SCS therapy parameters for managing upper limb pain. NANS 2022 Poster Presentation. Orlando, Finland (13–15 Jan 2021).
   Google Scholar
• Provenzano D , PeacockJ , FishmanMet al. A prospective multi-center study of a reduced-energy DTM stimulation derivative: long-term outcomes in therapy-naive patients. ASRA 2022 Poster Presentation. Orlando, Finland (17–19 Nov 2022).
   Google Scholar
• Provenzano D , AmirdelfanK , GrewalPet al. Modeling energy demands of a reduced-energy derivative of DTM stimulation on rechargeable and recharge-free SCS systems. ASRA 2022 Poster Presentation. Orlando, Finland (17–19 Nov 2022).
   Google Scholar
• Dombovy-Johnson ML , D’SouzaRS , ThucHa C , HagedornJM. Incidence and risk factors for spinal cord stimulator lead migration with or without loss of efficacy: a retrospective review of 91 consecutive thoracic lead implants. Neuromodulation25(5), 731–737 (2021).
   PubMed Web of Science ®Google Scholar
• Go A , ThackerJ , PereS , CedenoD , VallejoR. Lead migration during spinal cord stimulation trial using temporary leads after lumbar spine flexion. NANS Mid-Year 2021 Poster Presentation. Orlando, Finland (15–17 July 2021).
   Google Scholar
• Davies C , KomoroskiC , RoyL. Evaluation of an innovative spinal cord stimulator platform for the treatment of chronic pain. Pain Manag.8(3), 167–174 (2018).
   PubMedGoogle Scholar
• Medtronic . Intellis™ platform: spinal cord stimulation. www.medtronic.com/us-en/healthcare-professionals/products/neurological/spinal-cord-stimulation-systems/intellis-platform.html
   Google Scholar
• Deer TR , MekhailN , ProvenzanoDet al. The appropriate use of neurostimulation of the spinal cord and peripheral nervous system for the treatment of chronic pain and ischemic diseases: the neuromodulation appropriate-ness consensus committee. Neuromodulation17(6), 515–50 (2014).
   PubMed Web of Science ®Google Scholar